Evidence map›Paper›PMID 35763063›Full record

ArticleArchives of toxicology2022

Increased serum anti-CYP2E1 IgG autoantibody levels may be involved in the pathogenesis of occupational trichloroethylene hypersensitivity syndrome: a case-control study.

Tamie Nakajima, Hailan Wang, Yuan Yuan, Yuki Ito, Hisao Naito, Yoshiyuki Kawamoto, Kozue Takeda, Kiyoshi Sakai, Na Zhao, Hongling Li and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Tamie Nakajima *Research Institute of Life and Health Sciences, Chubu University, Kasugai, Aichi, 487-8501, Japan. tnasu23@med.nagoya-u.ac.jp.ORCID 0000-0002-0474-7019
Hailan Wang *Laboratory of Key Technology Research, Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Yuan YuanResearch Institute of Life and Health Sciences, Chubu University, Kasugai, Aichi, 487-8501, Japan.
Yuki ItoDepartment of Occupational and Environmental Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.ORCID 0000-0003-1617-1595
Hisao NaitoCollege of Human Life and Environment, Kinjo Gakuin University, Nagoya, Aichi, Japan.ORCID 0000-0003-4228-637X
Yoshiyuki KawamotoCollege of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan.
Kozue TakedaCollege of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan.
Kiyoshi SakaiDepartment of Occupational and Environmental Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Na ZhaoLaboratory of Key Technology Research, Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Hongling LiLaboratory of Key Technology Research, Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Xinxiang QiuPoison Control Center Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Lihua XiaPoison Control Center Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Jiabin ChenPoison Control Center Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Qifeng WuPoison Control Center Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Laiyu LiLaboratory of Key Technology Research, Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, People's Republic of China.
Hanlin HuangGuangdong Province Hospital for Women and Children Healthcare, Guangdong, People's Republic of China.
Yukie YanagibaDivision of Industrial Toxicology and Biological Monitoring, National Institute of Occupational Safety and Health, Kawasaki, Kanagawa, Japan.
Hiroshi YatsuyaDepartment of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.ORCID 0000-0002-6220-9251
Michihiro KamijimaDepartment of Occupational and Environmental Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.ORCID 0000-0003-0670-8790
Chubu University · JPGuangdong Provincial Occupational Disease Prevention Hospital · CNNagoya City University · JPGuangdong Province Women and Children Hospital · CNKinjo Gakuin University · JPNagoya University · JPNational Institute of Occupational Safety and Health · JP

Funding

Grants-in-Aid for the Challenging Exploratory Research 16K15383Grants-in-Aid for the Challenging Exploratory Research 18K19691
6 · The paper itself

Abstract

Occupational exposure to trichloroethylene (TCE) causes a systemic skin disorder with hepatitis known as TCE hypersensitivity syndrome (TCE-HS). Human Leukocyte Antigen (HLA)-B*13:01 is its susceptibility factor; however, the immunological pathogenesis of TCE-HS remains unknown. We herein examined the hypothesis that autoantibodies to CYP2E1 are primarily involved in TCE-HS. A case-control study of 80 TCE-HS patients, 186 TCE-tolerant controls (TCE-TC), and 71 TCE-nonexposed controls (TCE-nonEC) was conducted to measure their serum anti-CYP2E1 antibody (IgG) levels. The effects of TCE exposure indices, such as 8-h time-weighted-average (TWA) airborne concentrations, urinary metabolite concentrations, and TCE usage duration; sex; smoking and drinking habits; and alanine aminotransferase (ALT) levels on the antibody levels were also analyzed in the two control groups. There were significant differences in anti-CYP2E1 antibody levels among the three groups: TCE-TC > TCE-HS patients > TCE-nonEC. Antibody levels were not different between HLA-B*13:01 carriers and noncarriers in TCE-HS patients and TCE-TC. The serum CYP2E1 measurement suggested increased immunocomplex levels only in patients with TCE-HS. Multiple regression analysis for the two control groups showed that the antibody levels were significantly higher by the TCE exposure. Women had higher antibody levels than men; however, smoking, drinking, and ALT levels did not affect the anti-CYP2E1 antibody levels. Anti-CYP2E1 antibodies were elevated at concentrations lower than the TWA concentration of 2.5 ppm for TCE exposure. Since HLA-B*13:01 polymorphism was not involved in the autoantibody levels, the possible mechanism underlying the pathogenesis of TCE-HS is that TCE exposure induces anti-CYP2E1 autoantibody production, and HLA-B*13:01 is involved in the development of TCE-HS.

Indexed as

Cytochrome P-450 CYP2E1Drug Hypersensitivity SyndromeOccupational ExposureTrichloroethyleneAutoantibodiesCase-Control StudiesChemical and Drug Induced Liver InjuryFemaleHepatitis, AutoimmuneHLA-B AntigensHumansImmunoglobulin GMalePolymorphism, GeneticAutoantibodiesCytochrome P-450 CYP2E1HLA-B AntigensImmunoglobulin GTrichloroethyleneAlanine aminotransferaseAnti-cytochrome P450 2E1 autoantibody (IgG)Case–control studyHLA-B*13:01Hypersensitivity syndromeTrichloroethylene

Identifiers

PMID35763063
PMCPMC9352743
OpenAlexW4283659536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.